Immunonutrition in Patients with Pancreatic Cancer Undergoing Surgical Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview

Journal Nutrients

Date 2020 Sep 16

PMID 32932707

Citations 14

Authors

Fu-An Yang

Yang-Ching Chen

Cheng Tiong

Affiliations

Soon will be listed here.

Abstract

Immunonutrition is administered to improve the outcome of patients with pancreatic cancer undergoing surgery. However, its effect and mechanism of action remain unclear. Therefore, we conducted this systematic review and meta-analysis to assess its effects on postoperative outcome and the immune system. Randomized controlled trials (RCTs) were identified and data extracted by two reviewers independently from electronic databases from their inception to 31 October 2019. The result was expressed as the risk ratio (RR) for categorical variables and mean difference (MD) for continuous variables with 95% confidence intervals (CIs). Six RCTs published from 1999 and 2016, with a total of 368 patients, were included. The results revealed that immunonutrition significantly decreased the rate of infectious complications (RR = 0.47, 95% CI (0.23, 0.94), = 0.03) and the length of hospital stay (MD = -1.90, 95% CI (-3.78, -0.02), = 0.05) by modulating the immune system, especially in preoperative group in subgroup analysis. We therefore recommend that patients with pancreatic cancer undergoing surgery could take the advantage of immunonutrition, especially in the preoperative period.

Citing Articles

Addressing Inflammaging and Disease-Related Malnutrition: Adequacy of Oral Nutritional Supplements in Clinical Care.

Madini N, Vincenti A, Beretta A, Santero S, Viroli G, Cena H Nutrients. 2024; 16(23).

PMID: 39683535 PMC: 11643944. DOI: 10.3390/nu16234141.

Efficacy of a new immunonutrition formula with extra virgin olive oil in the reduction of complications in surgeries of upper digestive tract tumors.

Villar-Taibo R, Vidal-Casariego A, Santamaria-Nieto A, Canton-Blanco A, Crujeiras A, Lugo Rodriguez G Front Nutr. 2024; 11:1384145.

PMID: 38863591 PMC: 11165349. DOI: 10.3389/fnut.2024.1384145.

Perioperative Enteral Immunonutrition Support for the Immune Function and Intestinal Mucosal Barrier in Gastric Cancer Patients Undergoing Gastrectomy: A Prospective Randomized Controlled Study.

Ma M, Zheng Z, Zeng Z, Li J, Ye X, Kang W Nutrients. 2023; 15(21).

PMID: 37960219 PMC: 10647624. DOI: 10.3390/nu15214566.

Phase Angle and Postoperative Complications in a Model of Immunonutrition in Patients with Pancreatic Cancer.

Bockowska M, Kostro P, Kamocki Z Nutrients. 2023; 15(20).

PMID: 37892404 PMC: 10609395. DOI: 10.3390/nu15204328.

Immunonutrition in Radical Cystectomy: State of the Art and Perspectives.

Casirati A, Da Prat V, Bettiga A, Aretano L, Trevisani F, Cereda E Cancers (Basel). 2023; 15(14).

PMID: 37509408 PMC: 10378592. DOI: 10.3390/cancers15143747.

References

Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S . A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer. 2009; 101(6):908-15. PMC: 2743365. DOI: 10.1038/sj.bjc.6605256. View

Mohammed S, Van Buren 2nd G, Fisher W . Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014; 20(28):9354-60. PMC: 4110567. DOI: 10.3748/wjg.v20.i28.9354. View

Kudsk K, Wu Y, Fukatsu K, Zarzaur B, Johnson C, Wang R . Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. JPEN J Parenter Enteral Nutr. 2000; 24(5):270-4; discussion 274-5. DOI: 10.1177/0148607100024005270. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Drover J, Dhaliwal R, Weitzel L, Wischmeyer P, Ochoa J, Heyland D . Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg. 2011; 212(3):385-99, 399.e1. DOI: 10.1016/j.jamcollsurg.2010.10.016. View

Gianotti L, Braga M, Gentilini O, Balzano G, Zerbi A, Di Carlo V . Artificial nutrition after pancreaticoduodenectomy. Pancreas. 2000; 21(4):344-51. DOI: 10.1097/00006676-200011000-00004. View

Wong C, Aly E . The effects of enteral immunonutrition in upper gastrointestinal surgery: A systematic review and meta-analysis. Int J Surg. 2016; 29:137-50. DOI: 10.1016/j.ijsu.2016.03.043. View

Xu J, Zhong Y, Jing D, Wu Z . Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer. World J Surg. 2006; 30(7):1284-9. DOI: 10.1007/s00268-005-0756-8. View

Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y . Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg. 2009; 33(9):1815-21. DOI: 10.1007/s00268-009-0140-1. View

10.

Dinarello C . Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009; 27:519-50. DOI: 10.1146/annurev.immunol.021908.132612. View

11.

Manhart N, Vierlinger K, Akomeah R, Bergmeister H, Spittler A, Roth E . Influence of enteral diets supplemented with key nutrients on lymphocyte subpopulations in Peyer's patches of endotoxin-boostered mice. Clin Nutr. 2000; 19(4):265-9. DOI: 10.1054/clnu.2000.0123. View

12.

Wu G, Zhang Y, Wu Z . Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. World J Gastroenterol. 2002; 7(3):357-62. PMC: 4688722. DOI: 10.3748/wjg.v7.i3.357. View

13.

Gade J, Levring T, Hillingso J, Hansen C, Andersen J . The Effect of Preoperative Oral Immunonutrition on Complications and Length of Hospital Stay After Elective Surgery for Pancreatic Cancer--A Randomized Controlled Trial. Nutr Cancer. 2016; 68(2):225-33. DOI: 10.1080/01635581.2016.1142586. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

15.

Cameron J, Riall T, Coleman J, Belcher K . One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006; 244(1):10-5. PMC: 1570590. DOI: 10.1097/01.sla.0000217673.04165.ea. View

16.

Cheng Y, Zhang J, Zhang L, Wu J, Zhan Z . Enteral immunonutrition versus enteral nutrition for gastric cancer patients undergoing a total gastrectomy: a systematic review and meta-analysis. BMC Gastroenterol. 2018; 18(1):11. PMC: 5771223. DOI: 10.1186/s12876-018-0741-y. View

17.

Mayo S, Nathan H, Cameron J, Olino K, Edil B, Herman J . Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2011; 118(10):2674-81. PMC: 3578343. DOI: 10.1002/cncr.26553. View

18.

Aida T, Furukawa K, Suzuki D, Shimizu H, Yoshidome H, Ohtsuka M . Preoperative immunonutrition decreases postoperative complications by modulating prostaglandin E2 production and T-cell differentiation in patients undergoing pancreatoduodenectomy. Surgery. 2014; 155(1):124-33. DOI: 10.1016/j.surg.2013.05.040. View

19.

Grant J . On enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995; 221(4):325-6. PMC: 1234580. DOI: 10.1097/00000658-199504000-00001. View

20.

Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K . Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med. 2009; 15(6):633-40. DOI: 10.1038/nm.1968. View